These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 31207123)
21. Pulling the Brakes on Fast and Furious Multiple Drug-Resistant (MDR) Bacteria. Khan AA; Manzoor KN; Sultan A; Saeed M; Rafique M; Noushad S; Talib A; Rentschler S; Deigner HP Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467089 [TBL] [Abstract][Full Text] [Related]
22. Phage therapy in a lung transplant recipient with cystic fibrosis infected with multidrug-resistant Burkholderia multivorans. Haidar G; Chan BK; Cho ST; Hughes Kramer K; Nordstrom HR; Wallace NR; Stellfox ME; Holland M; Kline EG; Kozar JM; Kilaru SD; Pilewski JM; LiPuma JJ; Cooper VS; Shields RK; Van Tyne D Transpl Infect Dis; 2023 Apr; 25(2):e14041. PubMed ID: 36864824 [TBL] [Abstract][Full Text] [Related]
23. Role of bacteriophage therapy for resistant infections in transplant recipients. Nicholls P; Aslam S Curr Opin Organ Transplant; 2022 Dec; 27(6):546-553. PubMed ID: 36222821 [TBL] [Abstract][Full Text] [Related]
24. Multidrug-resistant bacteria in lung transplantation. Dominguez F; Blodget E Curr Opin Organ Transplant; 2020 Aug; 25(4):348-350. PubMed ID: 32618718 [TBL] [Abstract][Full Text] [Related]
26. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy. Tagliaferri TL; Jansen M; Horz HP Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237 [TBL] [Abstract][Full Text] [Related]
27. Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant Enterococcus: Three major threats to hematopoietic stem cell transplant recipients. Satlin MJ; Walsh TJ Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28815897 [TBL] [Abstract][Full Text] [Related]
28. Donor-derived bacterial infections in lung transplant recipients in the era of multidrug resistance. Bunsow E; Los-Arcos I; Martin-Gómez MT; Bello I; Pont T; Berastegui C; Ferrer R; Nuvials X; Deu M; Peghin M; González-López JJ; Lung M; Román A; Gavaldà J; Len O J Infect; 2020 Feb; 80(2):190-196. PubMed ID: 31843689 [TBL] [Abstract][Full Text] [Related]
29. Bacteriophages for ESKAPE: role in pathogenicity and measures of control. Patil A; Banerji R; Kanojiya P; Koratkar S; Saroj S Expert Rev Anti Infect Ther; 2021 Jul; 19(7):845-865. PubMed ID: 33261536 [TBL] [Abstract][Full Text] [Related]
30. Development of Host Immune Response to Bacteriophage in a Lung Transplant Recipient on Adjunctive Phage Therapy for a Multidrug-Resistant Pneumonia. Dan JM; Lehman SM; Al-Kolla R; Penziner S; Afshar K; Yung G; Golts E; Law N; Logan C; Kovach Z; Mearns G; Schooley RT; Aslam S; Crotty S J Infect Dis; 2023 Feb; 227(3):311-316. PubMed ID: 36082999 [TBL] [Abstract][Full Text] [Related]
31. Effect of positive perioperative donor and recipient respiratory bacterial cultures on early post-transplant outcomes in lung transplant recipients. Howell CK; Paciullo CA; Lyon GM; Neujahr D; Lyu P; Cotsonis G; Hurtik M Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28803455 [TBL] [Abstract][Full Text] [Related]
32. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial. Jault P; Leclerc T; Jennes S; Pirnay JP; Que YA; Resch G; Rousseau AF; Ravat F; Carsin H; Le Floch R; Schaal JV; Soler C; Fevre C; Arnaud I; Bretaudeau L; Gabard J Lancet Infect Dis; 2019 Jan; 19(1):35-45. PubMed ID: 30292481 [TBL] [Abstract][Full Text] [Related]
33. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going? Luong T; Salabarria AC; Roach DR Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528 [TBL] [Abstract][Full Text] [Related]
34. Bacteriophages as Adjuvant to Antibiotics for the Treatment of Periprosthetic Joint Infection Caused by Multidrug-Resistant Pseudomonas aeruginosa. Tkhilaishvili T; Winkler T; Müller M; Perka C; Trampuz A Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31527029 [TBL] [Abstract][Full Text] [Related]
35. Synergy between the Host Immune System and Bacteriophage Is Essential for Successful Phage Therapy against an Acute Respiratory Pathogen. Roach DR; Leung CY; Henry M; Morello E; Singh D; Di Santo JP; Weitz JS; Debarbieux L Cell Host Microbe; 2017 Jul; 22(1):38-47.e4. PubMed ID: 28704651 [TBL] [Abstract][Full Text] [Related]
36. Incidence and risk factors for respiratory tract bacterial colonization and infection in lung transplant recipients. Paglicci L; Borgo V; Lanzarone N; Fabbiani M; Cassol C; Cusi MG; Valassina M; Scolletta S; Bargagli E; Marchetti L; Paladini P; Luzzi L; Fossi A; Bennett D; Montagnani F Eur J Clin Microbiol Infect Dis; 2021 Jun; 40(6):1271-1282. PubMed ID: 33479881 [TBL] [Abstract][Full Text] [Related]
37. Multidrug-resistant Gram-negative bacterial infections in solid organ transplant recipients-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Pouch SM; Patel G; Clin Transplant; 2019 Sep; 33(9):e13594. PubMed ID: 31102483 [TBL] [Abstract][Full Text] [Related]